Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-139127
Filing Date
2016-08-12
Accepted
2016-08-12 07:02:45
Documents
79
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a16-11484_110q.htm 10-Q 1582185
2 EX-10.1 a16-11484_1ex10d1.htm EX-10.1 252386
3 EX-31.1 a16-11484_1ex31d1.htm EX-31.1 11195
4 EX-31.2 a16-11484_1ex31d2.htm EX-31.2 10587
5 EX-32.1 a16-11484_1ex32d1.htm EX-32.1 8988
  Complete submission text file 0001104659-16-139127.txt   7089760

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT neos-20160630.xml EX-101.INS 1156694
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT neos-20160630.xsd EX-101.SCH 67834
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT neos-20160630_cal.xml EX-101.CAL 57733
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT neos-20160630_def.xml EX-101.DEF 290769
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT neos-20160630_lab.xml EX-101.LAB 616436
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT neos-20160630_pre.xml EX-101.PRE 495532
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

EIN.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37508 | Film No.: 161826198
SIC: 2834 Pharmaceutical Preparations